CMS recently launched the Medicare GLP-1 Bridge, a short-term demonstration that provides eligible Part D beneficiaries with access to certain glucagon‐like peptide‐1 (GLP-1) drugs.
Denials rarely start at the payer. They often begin upstream, in the gaps between clinical, financial and quality workflows, where teams may be aligned in purpose but disconnected by process. In this fireside chat healthcare leaders...
CMS is considering fundamental changes to how it pays for professional services, according to the 2027 Medicare Physician Fee Schedule (MPFS) proposed rule. The proposed rule, released July 14, describes numerous potential changes to payments, codes, coverage, and more.
Hospitals could be facing lower reimbursement for non-drug items and services, 340B drugs, excepted off-campus provider-based department (PBD) services, as well as additional price transparency and prior authorization requirements, according to CMS’ 2027 Outpatient Prospective Payment System (OPPS) proposed rule.
CMS issues an annual Inpatient Prospective Payment System (IPPS) proposed rule, which details proposed changes to Medicare inpatient coding and billing.
During this 60-minute webinar, expert speakers Kimberly A. Hoy, JD, CPC, and Teri Rice, MSN, MHA, MBA, RN, CHC...
